N01266 114 — Pittsburgh, Pennsylvania

N01266 114 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

N01266 114 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma SA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01266 114?

N01266 114 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01266 114 conducted?

N01266 114 has 1 clinical trials on record. Their work covers Epilepsy.

Is N01266 114 accredited by Crixeo Health?

N01266 114 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01266 114?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.